JOURNAL
Current Issue
Journal Archive
 

Chief Editor -
Abdulrazak Abyad MD, MPH, MBA, AGSF, AFCHSE

.........................................................

Publisher -
Lesley Pocock
medi+WORLD International
AUSTRALIA
Email
: lesleypocock@mediworld.com.au
publishermwi@gmail.com
.........................................................

Editorial Enquiries -
abyad@cyberia.net.lb
.........................................................

Advertising Enquiries -
lesleypocock@mediworld.com.au
.........................................................

While all efforts have been made to ensure the accuracy of the information in this journal, opinions expressed are those of the authors and do not necessarily reflect the views of The Publishers, Editor or the Editorial Board. The publishers, Editor and Editorial Board cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; or the views and opinions expressed. Publication of any advertisements does not constitute any endorsement by the Publishers and Editors of the product advertised.

The contents of this journal are copyright. Apart from any fair dealing for purposes of private study, research, criticism or review, as permitted under the Australian Copyright Act, no part of this program may be reproduced without the permission of the publisher.

WFM / MEJFM May 2024

Terminal endpoints of systemic atherosclerotic processes in sickle cell diseases

Mehmet Rami Helvaci(1), Saziye Cayir(2), Hulya Halici(2), Alper Sevinc(1), Celaletdin Camci(1), Abdulrazak Abyad(3), Lesley Pocock(4)

(1) Specialist of Internal Medicine, MD, Turkey
(2) Manager of Writing and Statistics, Turkey
(3) Middle-East Academy for Medicine of Aging, MD, Lebanon
(4) medi-WORLD International, Australia

Corresponding author:
Prof Dr Mehmet Rami Helvaci, MD
07400, ALANYA, Turkey
Phone: 00-90-506-4708759
Email: mramihelvaci@hotmail.com

Received: March 2024. Accepted: April 2024; Published: May 1, 2024.Citation: Helvaci MR et al. Terminal endpoints of systemic atherosclerotic processes in sickle cell diseases. World Family Medicine. May 2024; 22(5): 13-23. DOI: 10.5742/MEWFM.2024.95257641


Abstract


Background: Sickle cell diseases (SCD) are severe inflammatory processes in the vasculature mainly on capillary endothelium since they are the main distributors of hardened red blood cells into the tissues. On the other hand, aging and male gender alone may be the most significant underlying risk factors of the systemic atherosclerosis since male gender lives about seven years shorter than female gender worldwide.

Methods: All patients with the SCD were included into the study.

Results: The study included 222 males and 212 females with similar mean ages (30.8 versus 30.3 years, p>0.05). Smoking (p<0.001), alcohol (p<0.001), disseminated teeth losses (p<0.001), ileus (p<0.001), cirrhosis (p<0.001), leg ulcers (p<0.001), digital clubbing (p<0.001), coronary heart disease (CHD) (p<0.05), chronic renal disease (CRD) (p<0.05), chronic obstructive pulmonary disease (COPD) (p<0.001), and stroke (p<0.05) were all higher in male gender. Interestingly, mean ages of stroke (33.5 years), COPD (33.6 years), clubbing (35.4 years), CHD (35.7 years), cirrhosis (37.0 years), and CRD (39.4 years) were the highest among the other atherosclerotic consequences.

Conclusion: Smoking, alcohol, disseminated teeth losses, ileus, cirrhosis, leg ulcers, digital clubbing, CHD, CRD, COPD, and stroke-like atherosclerotic risk factors or terminal endpoints were all higher in male gender with the SCD. Since aging alone may be the major associated factor of the systemic atherosclerosis, stroke, COPD, digital clubbing, CHD, cirrhosis, and CRD may be the terminal endpoints of systemic atherosclerotic processes in human body since the mean ages of the above pathologies were the highest among the other atherosclerotic consequences in the SCD.

Key words: Sickle cell diseases, atherosclerosis, stroke, chronic obstructive pulmonary disease, digital clubbing, coronary heart disease, cirrhosis, chronic renal disease

 





.................................................................................................................

I About MEJFM I Journal I Advertising I Author Info I Editorial Board I Resources I Contact us I Journal Archive I MEPRCN I Noticeboard I News and Updates
Disclaimer - ISSN 148-4196 - © Copyright 2007 medi+WORLD International Pty. Ltd. - All rights reserved